These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23764739)

  • 1. T helper type 2 bias and type 17 suppression in primary dengue virus infection in infants and young children.
    Talarico LB; Bugna J; Wimmenauer V; Espinoza MA; Quipildor MO; Hijano DR; Beccaria M; Wurster V; Cavagnaro LE; Martinez D; Fattore G; Batalle JP; Acosta PL; Reynoso N; Melendi GA; Rey FA; Libster R; Polack FP
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):411-9. PubMed ID: 23764739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper (Th) 1 and Th2 cytokine expression profile in dengue and malaria infection using magnetic bead-based bio-plex assay.
    Maneekan P; Leaungwutiwong P; Misse D; Luplertlop N
    Southeast Asian J Trop Med Public Health; 2013 Jan; 44(1):31-6. PubMed ID: 23682435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
    Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
    Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.
    Castanha PM; Braga C; Cordeiro MT; Souza AI; Silva CD; Martelli CM; van Panhuis WG; Nascimento EJ; Marques ET
    J Infect Dis; 2016 Jul; 214(2):265-72. PubMed ID: 27056951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].
    Hu D; Li J; Wang D; DI B; Qiu L; Wang Y; Ding X; Che X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1773-6, 1791. PubMed ID: 23268408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children.
    Pengsaa K; Luxemburger C; Sabchareon A; Limkittikul K; Yoksan S; Chambonneau L; Chaovarind U; Sirivichayakul C; Lapphra K; Chanthavanich P; Lang J
    J Infect Dis; 2006 Dec; 194(11):1570-6. PubMed ID: 17083042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue antibody in Thai children from maternally transferred antibody to acquired infection.
    Pengsaa K; Limkittikul K; Yoksan S; Wisetsing P; Sabchareon A
    Pediatr Infect Dis J; 2011 Oct; 30(10):897-900. PubMed ID: 21552182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Callithrix penicillata: a feasible experimental model for dengue virus infection.
    Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
    Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.
    Setthapramote C; Sasaki T; Puiprom O; Limkittikul K; Pitaksajjakul P; Pipattanaboon C; Sasayama M; Leuangwutiwong P; Phumratanaprapin W; Chamnachanan S; Kusolsuk T; Jittmittraphap A; Asai A; Arias JF; Hirai I; Kuhara M; Okuno Y; Kurosu T; Ramasoota P; Ikuta K
    Biochem Biophys Res Commun; 2012 Jul; 423(4):867-72. PubMed ID: 22713454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
    Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
    Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006.
    Mohammed H; Tomashek KM; Stramer SL; Hunsperger E
    Transfusion; 2012 Aug; 52(8):1652-6. PubMed ID: 22224623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.
    Poonpanichakul T; Chan-In W; Opasawatchai A; Loison F; Matangkasombut O; Charoensawan V; Matangkasombut P;
    Front Immunol; 2021; 12():599805. PubMed ID: 34079535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.